Abanti Goswami

Ms. Abanti Goswami

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 March 2024 in Indian Journal of Research in Homoeopathy
Verified
Journal Article
Open access
PDF file
AGAbanti Goswami
Abanti Goswami
NGNarasimha Kumar G.V
Narasimha Kumar G.V
VSVara Prasad Saka
Vara Prasad Saka
PGPankaj Gupta
Pankaj Gupta
BBBibaswan Biswas
Bibaswan Biswas
DVDigvijay Verma
Digvijay Verma
Background: Rhus toxicodendron (Rhus tox.) is a well-known homoeopathic medicine used to treat inflammatory disorders supported by historical and modern scientific evidence. Objective: The safety testing of 6C, 30C and 200C potencies of Rhus tox. through acute and sub-acute oral toxicity tests as per the Organisation for Economic Cooperation and Development test guidelines. Methods: For the acute oral toxicity study, Rhus tox. (2000 μL/kg) was administered to rats and observed for 14 days. For the subacute oral toxicity study, Rhus tox. (200 μL/kg) was administered for 28 days and additional recovery groups were included to monitor reversibility, persistence, or delayed occurrence of toxic effects for 14 days post-treatment. Histopathological assessments of vital organs were done to detect any signs of toxicity. Results: No mortality occurred during the acute toxicity study at a dose of 2000 μL/kg, indicating an oral LD50 of Rhus tox. >2000 μL/kg. In the sub-acute toxicity study, Rhus tox. administration for 28 days showed no adverse clinical signs, with normal weight gain and feed intake in treated animals. No adverse changes were noticed in the biochemical and haematological parameters of Rhus tox. treated rats. Furthermore, no abnormalities were observed in gross and histopathological examinations of vital organs. Conclusion: The study found that Rhus tox. in 6C, 30C and 200C potencies exhibited a safe toxicological profile, supporting its beneficial pharmacological effects.

8 August 2024 in Diseases
Verified
Journal Article
Open access
PDF file
VSVara Prasad Saka
Vara Prasad Saka
NGNarasimha Kumar G.V
Narasimha Kumar G.V
Bharat Kumar Reddy SanapalliBharat Kumar Reddy Sanapalli
Bharat Kumar Reddy Sanapalli
AGAbanti Goswami
Abanti Goswami
ARAnirban Roy
Anirban Roy
SKSubhash Kaushik
Subhash Kaushik
This study investigated how Rhus toxicodendron (RT) (6C, 30C, and 200C) can boost the immune system of BALB/c mice that were given cyclophosphamide (CPM), which is an anticancer drug that weakens the immune system. RT, known for its historical use in traditional homeopathic remedies, has demonstrated immunomodulatory and anti-inflammatory effects in various experimental models. To test the immune-boosting effects of RT, CPM (80 mg/kg) was given intraperitoneally to mice on days 4, 8, and 12 of the study but not to the normal control group. CPM-induced immunosuppression led to significant decreases in red blood cell (RBC), white blood cell (WBC), and hemoglobin (Hb) levels, and reduced spleen and thymus indices. Phagocytic activity, cytokine concentrations, and spleen architecture were also adversely affected. RT treatment, particularly at 200C, significantly ameliorated these effects, improving RBC, WBC, and Hb levels. Furthermore, RT partially prevented CPM-induced atrophy of immune organs. Treatment positively influenced cytokine production at both the protein and mRNA levels, restoring immune balance. Histopathological results confirmed that RT stimulated the immune system. The cells were more stable, and the white pulp in the spleen was arranged in a regular pattern. These findings suggest that RT may serve as an adjunctive immunostimulant therapy for conditions characterized by immunosuppression. However, further investigations in other immunocompromised states must validate these results before considering human clinical trials.

31 December 2024 in PLOS ONE
Verified
Journal Article
Open access
PDF file
VSVara Prasad Saka
Vara Prasad Saka
NGNarasimha Kumar G.V
Narasimha Kumar G.V
AGAbanti Goswami
Abanti Goswami
Bharat Kumar Reddy SanapalliBharat Kumar Reddy Sanapalli
Bharat Kumar Reddy Sanapalli
PGPankaj Gupta
Pankaj Gupta
SKSubhash Kaushik
Subhash Kaushik
Oxidative stress and inflammation are the most common pathologies in immune-compromised diseases and cancer treatments. The study examined the immune stimulation properties of Bryonia alba (BA) in different potencies (6C, 30C, and 200C) on a BALB/c mice model with a compromised immune system induced by cyclophosphamide (CPM) at a dose of 80 mg/kg. Seventy mice (35 males and 35 females) were randomly distributed into seven groups of 5 animals/sex. Mice treated with different potencies of BA showed notable improvements in various immune parameters, including RBC, WBC, and Hb levels, as well as thymus and phagocytic indices. Treatment also increased serum levels and splenic mRNA expression of IL-2, IL-4, TNF-α, and IFN-γ. The histopathology analysis showed that the spleen sections of the normal group exhibited intact white and red pulp. In contrast, the sections of the CPM group exhibited disrupted and atrophied white pulp. The treatment with BA maintained the spleen in a preserved state, with the white and red pulp remaining intact and a higher density of lymphocytes. The results indicate that BA could serve as a valued immunostimulant agent when administered with chemo-therapy. However, additional research is required to assess the immunostimulatory effects of BA in immune-compromised infections.

25 August 2026 in Pharmacological Research - Modern Chinese Medicine
Verified
Journal Article
Open access
VSVara Prasad Saka
Vara Prasad Saka
AGAbanti Goswami
Abanti Goswami
NGNarasimha Kumar G.V
Narasimha Kumar G.V
ADAnish Kumar Das
Anish Kumar Das
SNSatheesh Kumar Nanjappan
Satheesh Kumar Nanjappan
SKSubhash Kaushik
Subhash Kaushik

23 December 2025 in Toxicology Reports
Verified
Journal Article
Open access
AGAbanti Goswami
Abanti Goswami
VSVara Prasad Saka
Vara Prasad Saka
MSMahima Sharma
Mahima Sharma
NGNarasimha Kumar G.V.
Narasimha Kumar G.V.
PGPankaj Gupta
Pankaj Gupta
SKSubhash Kaushik
Subhash Kaushik